CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer Stage IIB
Interventions: DRUG: Hydroxychloroquine|DRUG: Everolimus
Sponsor: Abramson Cancer Center at Penn Medicine